Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade.
Schewe DM, Vogiatzi F, Münnich IA, Zeller T, Windisch R, Wichmann C, Müller K, Bhat H, Felix E, Mougiakakos D, Bruns H, Lenk L, Valerius T, Humpe A, Peipp M, Kellner C.
Schewe DM, et al. Among authors: bhat h.
Hemasphere. 2024 Feb 22;8(2):e48. doi: 10.1002/hem3.48. eCollection 2024 Feb.
Hemasphere. 2024.
PMID: 38435424
Free PMC article.